Hepatitis B Virus Vaccination Awareness and Coverage among Adults Attending Ophthalmology Clinic in Southeast, Nigeria
Published: 2024-02-26
Page: 104-113
Issue: 2024 - Volume 7 [Issue 1]
Arinze Anthony Onwuegbuna *
Department of Ophthalmology, Nnamdi Azikiwe University, Awka, Nigeria.
Akunne Ijeoma Apakama
Department of Ophthalmology, Nnamdi Azikiwe University, Awka, Nigeria.
Ugochukwu Anthony Eze
Department of Ophthalmology, Federal Medical Centre, Asaba, Nigeria.
Chidiebele Malachy Ezeude
Department of Internal Medicine, Nnamdi Azikiwe University, Awka, Nigeria.
Bernard Chukwunonyerem Ochiogu
Ophthalmology Unit, Department of Surgery, Chukwuemeka Odumegwu Ojukwu University, Awka, Nigeria.
Anthonia Chinyelu Udeaja
Ophthalmology Unit, Department of Surgery, Chukwuemeka Odumegwu Ojukwu University, Awka, Nigeria.
Emeka Akujuobi Chianakwalam
Department of Ophthalmology Federal Medical Centre Umuahia, Nigeria.
Charles Chukwudi Uzozie
Department of Ophthalmology, Nnamdi Azikiwe University, Awka, Nigeria.
Christiana Onyinye Ubaka
St. Joseph Eye Hospital Mgbirichi, Owerri, Nigeria.
Chisom God’swill Chigbo
School of public Health, University of Port-Harcourt, Nigeria.
George Uchenna Eleje
Department of Obstetrics and Gynecology, Faculty of Medicine, Nnamdi Azikiwe University, Awka, Nigeria.
*Author to whom correspondence should be addressed.
Abstract
Background: Hepatitis B virus (HBV) is a public health problem affecting millions of people globally and causing severe morbidity and mortality. Sub-Saharan Africa is an endemic region for HBV. But this infection is preventable.
Aim: To determine hepatitis B virus vaccination awareness and coverage among adults attending ophthalmology clinic in Anambra State, Nigeria.
Methods: This was a prospective, descriptive, cross-sectional survey to determine hepatitis B vaccination awareness and coverage among adults attending ophthalmology clinic in Anambra State, Nigeria using a pretested, self-administered and interviewer-administered semi-structured questionnaire. Information such as sociodemographics, awareness and knowledge of hepatitis B infection and hepatitis B vaccination were collected and analyzed using descriptive variables and tests of significance.
Results: A total of 264 participants were enrolled having met the inclusion criteria. There were 110(41.7%) males and 154(58,3%) females with a ratio of 1:1.4, and the age range of 20-87 years. The mean age was 60.6 years ± 14.8 years. Majority of the participants 96.6 % (n=255) were aware of HBV infection. However, 245(89.4%) do not know how HBV is transmitted. Also, 184(69.7%) do not know about HBV vaccination while 61(23.1%) subjects had received HBV vaccination at least once. Lack of awareness of vaccine is the main reason for not being vaccinated against HBV.
Conclusion: Hepatitis B vaccination coverage among adult patients attending ophthalmology clinic in Nigeria is poor. This is mostly due to lack of awareness of HBV vaccination.
Keywords: Eye clinic, HBV, Nigeria, vaccine coverage
How to Cite
References
CDC. Fast facts on global hepatitis; 2022 Available:Https://Www.Cdc.Gov/Globalhealth/Immunization/Diseases/Hepatitis-B/Data/Fast-Facts.Html
Accessed on August 8,2023.
Zeng DY, Li JM, Lin S, Dong X, You J, Xing QQ, et al. Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990-. J Hepatol. 2021;75(3):547-556. DOI: 10.1016/j.jhep.2021.04.03 Accessed on Epub 2021 May 4.
Sonderup MW, Spearman CW. Global disparities in hepatitis b elimination-a focus on Africa. Viruses. 2022;3;14(1):82. DOI: 10.3390/v14010082
Malu AO, Borodo MM, Ndububa DA, et al. Hepatitis B and C treatment guidelines for Nigeria. Niger J Gastroenterol Hepatol. 2015;7(2):63-75
Olayinka AT, Oyemakinde A, Balogun MS, Ajudua A, Nguku P, Aderinola M, et al. Seroprevalence of Hepatitis B Infection in Nigeria: A National Survey. Am J Trop Med Hyg. 2016;95(4):902-907.
DOI: 10.4269/ajtmh.15-0874. Epub 2016 Aug 15.
Okonkwo UC, Okpara H, Otu A, Ameh S, Ogarekpe Y, Osim H,et al Prevalence of hepatitis B, hepatitis C and human immunodeficiency viruses, and evaluation of risk factors for transmission: Report of a population screening in Nigeria. S Afr Med J. 2017;107(4):346-351.
DOI: 10.7196/SAMJ.2017.v107i4.12198
Eleje GU, Onubogu CU, Fiebai PO, Mbachu II, Akaba GO, Loto OM,et al. Triplex Infection in Pregnancy Collaboration Group1–36. Mother-to-child transmission of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among pregnant women with single, dual or triplex infections of human immunodeficiency virus, hepatitis B virus and hepatitis C virus in Nigeria: A systematic review and meta-analysis. SAGE Open Med. 2022;10 DOI: 10.1177/20503121221095411
Posuwan N, Wanlapakorn N, Sintusek P, Wasitthankasem R, Poovorawan K, Vongpunsawad S, Poovorawan Y. Towards the elimination of viral hepatitis in Thailand by the year 2030. J Virus Erad. 2020;6(3):100003. DOI: 10.1016/j.jve.2020.100003
Pol S, Lair-Mehiri L, Vallet-Pichard A. Is elimination of HCV realistic by 2030: France. Liver Int. 2021;41 Suppl1:45-49. doi: 10.1111/liv.14862.
Eleje GU, Loto OM, Usman HA, Onubogu CU, Fiebai PO, Akaba GO, et al. A Systematic Review and Meta-Analysis of the Prevalence of Triplex Infections (Combined Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus) among Pregnant Women in Nigeria. Obstet Gynecol Int. 2023;17; 2023:3551297. DOI: 10.1155/2023/3551297
Eleje GU, Akaba GO, Mbachu II, Rabiu A, Loto OM, Usman HA, et al.; Triplex Infection in Pregnancy Collaboration Group. Pregnant women's hepatitis B vaccination coverage in Nigeria: A national pilot cross-sectional study. Ther Adv Vaccines Immunother.2021;9. DOI: 10.1177/25151355211032595
Hepatitis B Foundation: Hepatitis B Vaccine Schedules; 2022 Available:https://www.hepb.org. Accessed December 10, 2023.
Issa A, Ayoola, YA., Abdulkadir, M.B. et al. Hepatitis B vaccination status among health workers in Nigeria: A nationwide survey between January to June 2021. Arch Public Health. 2023; 81:123. Available:https://doi.org/10.1186/s13690-023-01142-y
Onwuegbuna AA, Chianakwalam AA, Amobi MB, Apakama AA, Okosa MC, Chigbo CG, et al. Prevalence of Hepatitis B virus Infection Among Cataract Patients in South-East Nigeria. J of Oph and Res. 2021;4:221-230
OnwuegbunaAA, Amobi MB, Chianakwalam EA, Okosa MC, Apakama AI, Chigbo CG, et al. Prevalence of blood borne viral infections among glaucoma patients in south-east, Nigeria. Magna Scientia Advanced Research and Reviews. 2022; 05(01):001–009.
Onwuegbuna AA, Apakama AI, Okosa MC, Chianakwalam EA, Amobi MB, Chigbo CG, et al. Seroprevalence of HIV infection among cataract surgery patients in south-east Nigeria: A retrospective cross-sectional study. Magna Scientia Advanced Biology and Pharmacy. 2021; 03(02): 001–008
Onwuegbuna AA, Apakama AI, Chianakwalam CE, Chigbo CG, Eleje GU. Pattern of HIV, Hepatitis B and Hepatitis C Viral Infections among Pterygium Patients in Onitsha, Nigeria. Trop J Med Res. 2023; 22(1):41- 48.
Onwuegbuna AA, Amobi MC, Chianakwalam EA, Okosa CM, Apakama AI, Chigbo CG, et al. Rates of Hepatitis C Virus Infection Among Cataract Patients in a Specialist Health Facility in South-East Nigeria. J Surg Res. 2021;04(03):399–405.
Tsachouridou O, Georgiou A, Naoum S, Vasdeki D, Papagianni M, Kotoreni G, Forozidou E, Tsoukra P, Gogou C, Chatzidimitriou D, Skoura L, Zebekakis P, Metallidis S. Factors associated with poor adherence to vaccination against hepatitis viruses, streptococcus pneumoniae and seasonal influenza in HIV-infected adults. Hum Vaccin Immunother. 2019;15(2):295-304.
DOI: 10.1080/21645515.2018.1509644
Ali AS, Hussein NA, Elmi EOH, Ismail AM, Abdi MM. Hepatitis B vaccination coverage and associated factors among medical students: a cross-sectional study in Bosaso, Somalia, 2021. BMC Public Health. 2023;23(1):1060. DOI: 10.1186/s12889-023-15992-2
Gagneux-Brunon A, Fresard A, Lucht F, Botelho-Nevers E. Vaccine coverage in PLWH: disparities and potential impact of vaccine hesitancy. Hum Vaccin Immunother. 2019;15(2):305-306.
DOI:10.1080/21645515.2018.1534517. Epub 2018 Oct 25.
Eze U, Osiyemi A, Alao A, Ndoh K, Ibisola B, Ude N, Onwuliri C, Chime A, Ogbor E, Abdullahi A. COVID-19 Pandemic: A Survey of its Knowledge and Risk Perception among Nigerians. Niger Med J 2023; 64(1): 80-86
Afolabi IB, Aremu AB, Maidoki LA, Atulomah NO. Predictors of Hepatitis B Virus Infection Vaccine Hesitancy Among Pregnant Women Attending Antenatal Care at Lubaga Hospital, Kampala, Uganda. Int J Womens Health. 2022, 17;14:1093-1104.
Bigica A. Vaccine Hesitancy Among the Top Barriers to Hepatitis Eradication (2023) Available:https://www.contagionlive.com. Accessed December 10, 2023.
Vraga EK, Brady SS, Gansen C, Khan EM, Bennis SL, Nones M, Tang R, Srivastava J, Kulasingam S. A review of HPV and HBV vaccine hesitancy, intention, and uptake in the era of social media and COVID-19. Elife. 2023;12:e85743.
Dagnew M, Million Y, Destaw B, Adefris M, Moges F, Tiruneh M. Knowledge, Attitude, and Associated Factors Towards Vertical Transmission of Hepatitis B Virus Among Pregnant Women Attending Antenatal Care in Tertiary Hospitals in Amhara Region, Northwest Ethiopia: A Cross-Sectional Study. Int J Womens Health. 2020 Oct 16;12 :859-868. DOI: 10.2147/IJWH.S273560
Han Z, Yin Y, Zhang Y, Ehrhardt S, Thio CL, Nelson KE, Bai X, Hou H. Knowledge of and attitudes towards hepatitis B and its transmission from mother to child among pregnant women in Guangdong Province, China. PLoS One. 2017;12(6): e0178671. DOI: 10.1371/journal.pone.0178671
Okonkwo U, Otu A, Ameh S, Okpara H. Public Awareness of Hepatitis B Virus Infection in Cross River State, Nigeria: A Population-Based Survey. West Afr J Med. 2018;35(2):79-84